Technical Groups - Universal Access to Medicines

The purpose of the group is to develop strategies and working plans to improve access to medicines in the South American region. Among the expected results for this WG are: the development of a policy on access to medicines and recommendations to strengthen coordination of productive capacities in the region; the reduction of access barriers; the formulation of a proposal for the creation of a pricing policy, as well as promoting the production and use of generic medicines, among others.

 

 

 

Information GAUMU

Coordinator: Argentina
Alternate Coordinator: Suriname

News

18/09/2018

Universal Access to Essential Medicines: Recent South American Experiences and Challenges for the Region

        Health as a fundamental right and regional integration are part of the welfare goals agreed upon by all countries in South America. Although we have some achievements in access to medicines, it is a priority to seek and promote regional access scenarios that do not violate the precepts of essentiality and […]

12/04/2018

Consultative Council gathers to propose an agenda for 2019

The ISAGS Consultative Council met between April 11 and 12 at the Institute’s headquarters in Rio de Janeiro, to discuss and propose actions for the next year of work. Representatives from 8 UNASUR countries, including members of the ministries, technical groups and structuring networks of the South American Health Council, as well as ISAGS officials […]

09/01/2018

The Mapping of Productive Capacity of Medicines and Health Supplies of the South American Region was launched

As the Executing Entity of the project, ISAGS will support GAUMU for the successful implementation of the project, which is of great relevance to the South American region in its drive to count as Universal Health Systems, recognizing health as a fundamental right of its population.

06/01/2018

Regulation of Prices of Medicines in South America: Results and Concrete Strategies of Colombia

In general, medicines are an important component of health spending. Data on total pharmaceutical expenditure confirms that medicines have an important share in the total health expenditure, while this proportion varies considerably between low- and high-income countries, from a 19.7% participation in high income countries to a 30.4% in low-income countries (WHO 2011). The pharmaceutical […]

04/12/2017

The Shadow of Monopolies in the Pharmaceutical Industry

How anti-competitive practices ensure exorbitant profits while limiting the ability of Health Systems to save lives In the annals of liberal economic theories, competition stands out as a fundamental aspect to the functioning of capitalism. In its perfect version, the market would be made up of multiple consumers and multiple producers (aggregate demand and aggregate […]

02/11/2017

Judicialization of medicines: right to health or symptoms of weaknesses in our systems?

Despite posing complex challenges, the principle that health is a fundamental right has guided the work of the South American regional health integration. How can these universal health systems be sustainable? Although UNASUR Member States have achievements towards the universal access to medicines at regional level, they face a vulnerable situation at certain occasions. Particularly, […]